Social Links

Follow on Facebook Follow on TwitterFollow EiR on PinterestFollow EiR on Instagram

Xpert Access


Login To Get Involved!

Forgot your username?

Forgot your password?


Join Us At EiR Now!

DNRS Roof Banner


DNRS Interactive DVD Series & Seminars

The effect of hepar magnesium on seasonal fatigue symptoms





J Altern Complement Med. 2008 May;14(4):395-402.


The effect of hepar magnesium on seasonal fatigue symptoms: a pilot study.


Baars EW, Gans S, Ellis EL. Healthcare & Nutrition Department, Louis Bolk Instituut, Driebergen, The Netherlands. This email address is being protected from spambots. You need JavaScript enabled to view it.



OBJECTIVES: To evaluate the effect of the anthroposophic drug hepar magnesium D10 intravenously administered on seasonal fatigue symptoms.


DESIGN: Time series with two measurements per week, starting before onset of treatment until three measurements after finishing treatment in a regular way.


SETTINGS: Six anthroposophic general practitioner practices in the Netherlands.


SUBJECTS: Twenty-three (23) patients with seasonal fatigue symptoms.


INTERVENTIONS: Hepar magnesium D10 intravenously administered every week.


OUTCOME MEASURES: Mean division of 24 hours in categories: sleep, rest, everyday activities, and activities that require a large effort; fatigue-related single questions: unusual emotional response to events, problems with short-term memory, the degree to which fatigue after effort continues for longer than 2 hours, the degree to which people at the end of the day have a complete lack of energy; and the degree to which people are still fit after the evening meal; Multidimensional Fatigue Index: general fatigue, physical fatigue, reduced activity, reduced motivation, and mental fatigue; subjective experiences with regard to the effect of the treatment.


RESULTS: (1) No changes in division in 24-hour categories were found; (2) pretreatment versus post-treatment analyses (after 1 and 2.5 weeks, at the end of treatment, and 1.5 weeks after the end of treatment) demonstrated overall large statistically significant differences. Eighteen (18) of 22 patients (82%) who completed the final questionnaire judged that treatment overall had been effective for their fatigue symptoms. Nine (9) patients (41%) judged a strong improvement and 9 patients (41%) a light improvement as a result of the treatment. Four (4) patients reported no change. On average, patients received treatment 4.5 times.


CONCLUSIONS: There are clear indications that hepar magnesium D10 intravenously administered can have a positive effect on subsyndromal seasonal affective disorder symptoms of fatigue. A more controlled trial is indicated to study the (long-term) effects of hepar magnesium.


PMID: 18576923 [PubMed - indexed for MEDLINE]










Related Articles:


Home Testing & Sanitizer:







  • No comments found

Leave your comments

Post comment as a guest

0 Character restriction
Your text should be more than 25 characters
Your comments are subjected to administrator's moderation.
terms and condition.

Adsense Responsive BottomBanner